Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: Abnormal DNA methylation analysis of leucine-rich glioma-inactivated 1 antibody encephalitis reveals novel methylation-driven genes related to prognostic and clinical features

Fig. 2

Immune checkpoint molecular levels in serum between the patients with LGI1 encephalitis and normal donors. A–F There were significant differences in serum level of CD28, ICOSL, PD-L2, PD1, ICOS and CD86 between anti-LGI1 encephalitis and normal donors. LGI1-E anti-leucine-rich glioma inactivated-1 encephalitis; ND normal donor. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us